These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34776013)

  • 1. Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru.
    Schwalb A; Cachay R; Meza E; Cáceres T; Blackman A; Maruri F; Sterling TR; Gotuzzo E
    BMC Res Notes; 2021 Nov; 14(1):413. PubMed ID: 34776013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline resistance and cross-resistance among fluoroquinolones in multidrug-resistant Mycobacterium tuberculosis isolates at a national reference laboratory in India.
    Mamatha HG; Shanthi V
    J Glob Antimicrob Resist; 2018 Mar; 12():5-10. PubMed ID: 28887289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New generation fluoroquinolone sitafloxacin could potentially overcome the majority levofloxacin and moxifloxacin resistance in multidrug-resistant
    Sun Q; Cheng K; Liao X; Zhao W; Wang C; Wang C; Yan J; Dong L; Wang F; Jiang G; Huang H; Guo Z; Wang G
    J Med Microbiol; 2024 Jul; 73(7):. PubMed ID: 39028256
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China.
    Zhang Z; Lu J; Wang Y; Pang Y; Zhao Y
    Antimicrob Agents Chemother; 2014; 58(1):364-9. PubMed ID: 24165186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone Resistance Among Isolates of
    Ali S; Khan MT; Khan AS; Abbas Q; Irfan M
    Microb Drug Resist; 2021 Jun; 27(6):786-791. PubMed ID: 33124944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Chien JY; Chiu WY; Chien ST; Chiang CJ; Yu CJ; Hsueh PR
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2090-6. PubMed ID: 26787695
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Tudó G; Lopez-Gavin A; Portell-Buj E; Freixes J; Vila J; Roman A; Monté MR; Gonzalez-Martin J
    Microb Drug Resist; 2020 Sep; 26(9):1019-1022. PubMed ID: 32159449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.
    Willby M; Sikes RD; Malik S; Metchock B; Posey JE
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5427-34. PubMed ID: 26100699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
    Nosova EY; Bukatina AA; Isaeva YD; Makarova MV; Galkina KY; Moroz AM
    J Med Microbiol; 2013 Jan; 62(Pt 1):108-113. PubMed ID: 23019190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of trends of ofloxacin resistance in Mycobacterium tuberculosis.
    Verma JS; Nair D; Rawat D; Manzoor N
    Indian J Med Microbiol; 2011; 29(3):280-2. PubMed ID: 21860110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran.
    Sayadi M; Zare H; Jamedar SA; Hashemy SI; Meshkat Z; Soleimanpour S; Hoffner S; Ghazvini K
    BMC Infect Dis; 2020 Jun; 20(1):390. PubMed ID: 32487030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern and characteristics of mutations conferring resistance to second line drugs in Mycobacterium tuberculosis isolates of pulmonary and extrapulmonary TB samples.
    Dixit R; Mohan E; Gupta A; Patni T
    Indian J Tuberc; 2024; 71 Suppl 1():S37-S43. PubMed ID: 39067953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
    Wang JY; Lee LN; Lai HC; Wang SK; Jan IS; Yu CJ; Hsueh PR; Yang PC
    J Antimicrob Chemother; 2007 May; 59(5):860-5. PubMed ID: 17412727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microcolonies in fluoroquinolone agar proportion susceptibility testing of Mycobacterium tuberculosis: an indicator of drug resistance.
    Blackman A; May S; Devasia RA; Maruri F; Stratton C; Sterling TR
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2177-82. PubMed ID: 22322359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects of ciprofloxacin, levofloxacin and moxifloxacin on Mycobacterium tuberculosis isolates.
    Yılmaz FF; Eraç B; Ermertcan Ş; Çavuşoğlu C; Biçmen C; Aktoğu Özkan S; Hoşgör Limoncu M
    Tuberk Toraks; 2018 Mar; 66(1):32-36. PubMed ID: 30020039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin.
    Yu X; Wang G; Chen S; Wei G; Shang Y; Dong L; Schön T; Moradigaravand D; Parkhill J; Peacock SJ; Köser CU; Huang H
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5232-7. PubMed ID: 27324769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant Tuberculosis.
    Chien JY; Chien ST; Chiu WY; Yu CJ; Hsueh PR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4708-16. PubMed ID: 27216062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype analysis of ofloxacin-resistant multidrug-resistant
    Gupta A; Sinha P; Rathod S; Shanmugam SK; Uma Devi KR; Anupurba S; Nema V
    Indian J Med Res; 2020 Apr; 151(4):361-370. PubMed ID: 32461400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
    Singh P; Jain A; Dixit P; Prakash S; Jaiswal I; Venkatesh V; Singh M
    J Antibiot (Tokyo); 2015 Jan; 68(1):63-6. PubMed ID: 25052485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
    Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
    Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.